Skip to Content

9 3 7160 (Pergolide Mesylate 0.05 mg)

Pill with imprint 9 3 7160 is White, Elliptical / Oval and has been identified as Pergolide Mesylate 0.05 mg. It is supplied by Teva Pharmaceuticals USA.

Pergolide is used in the treatment of hyperprolactinemia; parkinson's disease; tourette's syndrome and belongs to the drug class dopaminergic antiparkinsonism agents. There is no proven risk in humans during pregnancy. Pergolide 0.05 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 9 3 7160

Pergolide mesylate 0.05 mg 9 3 7160

Pergolide Mesylate

Imprint
9 3 7160
Strength
0.05 mg
Color
White
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-7160

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.